Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00131
|
|||||
| Drug Name |
Sucrose
|
|||||
| Synonyms |
57-50-1; Amerfand; Amerfond; Beet sugar; CCRIS 2120; CHEBI:17992; Cane sugar; Confectioner's sugar; D(+)-Saccharose; D(+)-Sucrose; D-(+)-Saccharose; D-Saccharose; D-Sucrose; Granulated sugar; HSDB 500; Microse; Rock candy; Rohrzucker; Saccharose; Saccharum; Sacharose; Sucraloxum [INN-Latin]; Sucrose [USAN:JAN]; Sucrose, dust; Sucrose, pure; Table sugar; White sugar; alpha-D-Glucopyranosyl beta-D-fructofuranoside; beta-D-Fructofuranosyl alpha-D-glucopyranoside; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; sacarosa; sugar
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Retinopathy of prematurity [ICD11: 9B71.3] | Phase 4 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C12H22O11
|
|||||
| Canonical SMILES |
C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O)O
|
|||||
| InChI |
InChI=1S/C12H22O11/c13-1-4-6(16)8(18)9(19)11(21-4)23-12(3-15)10(20)7(17)5(2-14)22-12/h4-11,13-20H,1-3H2/t4-,5-,6-,7-,8+,9-,10+,11-,12+/m1/s1
|
|||||
| InChIKey |
CZMRCDWAGMRECN-UGDNZRGBSA-N
|
|||||
| CAS Number |
CAS 57-50-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 342.3 | Topological Polar Surface Area | 190 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 8 | Hydrogen Bond Acceptor Count | 11 | |||
| XLogP |
-3.7
|
|||||
| PubChem CID | ||||||
| PubChem SID |
3137376
, 3194
, 3389
, 6436115
, 6436116
, 6436204
, 7847093
, 7887852
, 7890628
, 8011621
, 8011923
, 8020622
, 8022577
, 8024860
, 8024864
, 8027366
, 8028161
, 8143928
, 8153723
, 818878
, 820865
, 823014
, 823458
, 823537
, 825314
, 825582
, 825586
, 826415
, 826659
, 826950
, 826952
, 826953
, 827036
, 828601
, 828646
, 829805
, 831374
, 832319
, 832408
, 833228
, 833813
, 838627
, 839070
, 839082
, 839090
, 841538
, 854919
, 855298
, 855299
, 855300
|
|||||
| ChEBI ID |
CHEBI:17992
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | SLC45A2 | Transporter Info | Membrane-associated transporter protein | Substrate | [2] | |
| SLC45A3 | Transporter Info | Solute carrier family 45 member 3 | Substrate | [3] | ||
| SLC45A4 | Transporter Info | Solute carrier family 45 member 4 | Substrate | [4] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT00921544) Sucrose Analgesia for the Reduction of Pain During Retinopathy of Prematurity Screening | |||||
| 2 | Identification of amino acids important for substrate specificity in sucrose transporters using gene shuffling. J Biol Chem. 2012 Aug 31;287(36):30296-304. | |||||
| 3 | Putative role of the H(+)/sucrose symporter SLC45A3 as an osmolyte transporter in the kidney. Pflugers Arch. 2016 Aug;468(8):1353-62. | |||||
| 4 | The SLC45 gene family of putative sugar transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):655-60. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.